BCL9 and colorectal carcinoma: De La Roche and co-workers identified some natural compounds, including the carnosic acid (31) from rosemary, that inhibited, in a dose-dependent manner, the binding of β-catenin to BCL9 in vitro, and β-catenin-dependent transcription in CRC cells [61].